Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Agents and Actions|March 1, 1990
Naphthalenes as inhibitors of myeloperoxidase: direct and indirect mechanisms of inhibitionR W Egan, W K Hagmann, P H GaleBiochemistry|February 15, 1994
Studies on the kinetic and chemical mechanism of inhibition of stromelysin by an N-(carboxyalkyl)dipeptideM Izquierdo-Martin, K T Chapman, W K Hagmann, et al.International Journal of Immunopharmacology|January 1, 1990
Steroidal glycolipid, L-644,257, is a potent enhancer of nonspecific host resistanceW K Hagmann, M M Ponpipom, J J Jackson, et al.Journal of Medicinal Chemistry|February 1, 1990
Glycolipids as host resistance stimulatorsM M Ponpipom, W K Hagmann, L A O'Grady, et al.Journal of Medicinal Chemistry|August 1, 1986
Synthesis and antiinflammatory/analgesic activities of 11H-dibenzo[b, e,][1,4]dioxepinacetic acidsW K Hagmann, C P Dorn, R A Frankshun, et al.Biochemistry|May 19, 1992
Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzymeS P Salowe, A I Marcy, G C Cuca, et al.Biochemistry|December 7, 1993
Secondary structure and zinc ligation of human recombinant short-form stromelysin by multidimensional heteronuclear NMRP R Gooley, B A Johnson, A I Marcy, et al.Journal of Biomolecular NMR|January 1, 1996
Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallographyP R Gooley, J F O'Connell, A I Marcy, et al.Journal of Medicinal Chemistry|January 24, 1992
Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor bindingT J Lanza, P L Durette, T Rollins, et al.Biochemistry|July 2, 1991
Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated formA I Marcy, L L Eiberger, R Harrison, et al.Pageof 3